{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T12:15:08Z","timestamp":1753272908992},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,31]]},"DOI":"10.7759\/cureus.48079","type":"journal-article","created":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T05:35:56Z","timestamp":1698816956000},"source":"Crossref","is-referenced-by-count":2,"title":["Clinical Profile and Treatment Outcomes of Malignant Mixed Mullerian Tumors of the Uterus: A Single-Center Experience"],"prefix":"10.7759","author":[{"given":"Niranjan","family":"Vijayaraghavan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinesh","family":"Ravikumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2009.0037","article-title":"Carcinosarcomas (malignant mixed M\u00fcllerian tumor) of the uterus: advances in elucidation of biologic and clinical characteristics","volume":"7","author":"Kernochan LE","year":"2009","unstructured":"Kernochan LE, Garcia RL. Carcinosarcomas (malignant mixed M\u00fcllerian tumor) of the uterus: advances in elucidation of biologic and clinical characteristics. J Natl Compr Canc Netw. 2009, 7:550-6; quiz 557. 10.6004\/jnccn.2009.0037","journal-title":"J Natl Compr Canc Netw"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-015-3993-6","article-title":"Outcome and prognosis in uterine sarcoma and malignant mixed Mullerian tumor","volume":"294","author":"Burghaus S","year":"2016","unstructured":"Burghaus S, Halmen S, Gass P, et al.. Outcome and prognosis in uterine sarcoma and malignant mixed Mullerian tumor. Arch Gynecol Obstet. 2016, 294:343-51. 10.1007\/s00404-015-3993-6","journal-title":"Arch Gynecol Obstet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(03)01561-X","article-title":"Malignant mixed M\u00fcllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome","volume":"58","author":"Callister M","year":"2004","unstructured":"Callister M, Ramondetta LM, Jhingran A, Burke TW, Eifel PJ. Malignant mixed M\u00fcllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome. Int J Radiat Oncol Biol Phys. 2004, 58:786-96. 10.1016\/S0360-3016(03)01561-X","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref4","article-title":"The epidemiology of sarcomas of the uterus","volume":"76","author":"Harlow BL","year":"1986","unstructured":"Harlow BL, Weiss NS, Lofton S. The epidemiology of sarcomas of the uterus. J Natl Cancer Inst. 1986, 76:399-402.","journal-title":"J Natl Cancer Inst"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/470795","article-title":"Uterine carcinosarcomas (malignant mixed M\u00fcllerian tumours): a review with special emphasis on the controversies in management","volume":"2011","author":"Kanthan R","year":"2011","unstructured":"Kanthan R, Senger JL. Uterine carcinosarcomas (malignant mixed M\u00fcllerian tumours): a review with special emphasis on the controversies in management. Obstet Gynecol Int. 2011, 2011:470795. 10.1155\/2011\/470795","journal-title":"Obstet Gynecol Int"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.99.174","article-title":"Increased risk of malignant Mullerian tumor of the uterus among women with breast cancer treated by tamoxifen","volume":"20","author":"Bouchardy C","year":"2002","unstructured":"Bouchardy C, Verkooijen HM, Fioretta G, Sappino AP, Vlastos G. Increased risk of malignant Mullerian tumor of the uterus among women with breast cancer treated by tamoxifen. J Clin Oncol. 2002, 20:4403. 10.1200\/JCO.2002.99.174","journal-title":"J Clin Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djh007","article-title":"Risk of malignant mixed Mullerian tumors after tamoxifen therapy for breast cancer","volume":"96","author":"Curtis RE","year":"2004","unstructured":"Curtis RE, Freedman DM, Sherman ME, Fraumeni JF Jr. Risk of malignant mixed Mullerian tumors after tamoxifen therapy for breast cancer. J Natl Cancer Inst. 2004, 96:70-4. 10.1093\/jnci\/djh007","journal-title":"J Natl Cancer Inst"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S1028-4559(09)60260-6","article-title":"Irradiation-induced uterine malignant mixed m\u00fcllerian tumor","volume":"45","author":"Huang YT","year":"2006","unstructured":"Huang YT, Huang KG, Ueng SH, Shaw SW. Irradiation-induced uterine malignant mixed m\u00fcllerian tumor. Taiwan J Obstet Gynecol. 2006, 45:353-5. 10.1016\/S1028-4559(09)60260-6","journal-title":"Taiwan J Obstet Gynecol"},{"key":"ref9","article-title":"Malignant mixed Mullerian tumours of the uterus-a ten-year experience","volume":"43","author":"Ho SP","year":"2002","unstructured":"Ho SP, Ho TH. Malignant mixed Mullerian tumours of the uterus-a ten-year experience. Singapore Med J. 2002, 43:452-6.","journal-title":"Singapore Med J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2011.22.2.83","article-title":"Which is worse: uterine papillary serous carcinomas or carcinosarcomas?","volume":"22","author":"Song T","year":"2011","unstructured":"Song T, Choi CH, Lee YY, Kim TJ, Lee JW, Kim BG, Bae DS. Which is worse: uterine papillary serous carcinomas or carcinosarcomas?. J Gynecol Oncol. 2011, 22:83-8. 10.3802\/jgo.2011.22.2.83","journal-title":"J Gynecol Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2009.10.053","article-title":"The impact of multi-modal therapy on survival for uterine carcinosarcomas","volume":"116","author":"Gonzalez Bosquet J","year":"2010","unstructured":"Gonzalez Bosquet J, Terstriep SA, Cliby WA, Brown-Jones M, Kaur JS, Podratz KC, Keeney GL. The impact of multi-modal therapy on survival for uterine carcinosarcomas. Gynecol Oncol. 2010, 116:419-23. 10.1016\/j.ygyno.2009.10.053","journal-title":"Gynecol Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2013.302","article-title":"Malignant mixed Mullerian tumour of the uterus","volume":"7","author":"Rajshekar SK","year":"2013","unstructured":"Rajshekar SK, Guruprasad B, Shakunthala P, Rathod P, Devi U, Bafna U. Malignant mixed Mullerian tumour of the uterus. Ecancermedicalscience. 2013, 7:302. 10.3332\/ecancer.2013.302","journal-title":"Ecancermedicalscience"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.06.4907","article-title":"Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: a Gynecologic Oncology Group Study","volume":"25","author":"Homesley HD","year":"2007","unstructured":"Homesley HD, Filiaci V, Markman M, et al.. Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: a Gynecologic Oncology Group Study. J Clin Oncol. 2007, 25:526-31. 10.1200\/JCO.2006.06.4907","journal-title":"J Clin Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2023.0006","article-title":"Uterine neoplasms, version 1.2023, NCCN Clinical Practice Guidelines in Oncology","volume":"21","author":"Abu-Rustum N","year":"2023","unstructured":"Abu-Rustum N, Yashar C, Arend R, et al.. Uterine neoplasms, version 1.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2023, 21:181-209. 10.6004\/jnccn.2023.0006","journal-title":"J Natl Compr Canc Netw"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.8326","article-title":"Phase II evaluation of paclitaxel and carboplatin in the treatment of carcinosarcoma of the uterus: a Gynecologic Oncology Group study","volume":"28","author":"Powell MA","year":"2010","unstructured":"Powell MA, Filiaci VL, Rose PG, et al.. Phase II evaluation of paclitaxel and carboplatin in the treatment of carcinosarcoma of the uterus: a Gynecologic Oncology Group study. J Clin Oncol. 2010, 28:2727-31. 10.1200\/JCO.2009.26.8326","journal-title":"J Clin Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2004.12.006","article-title":"A comparison between different postoperative treatment modalities of uterine carcinosarcoma","volume":"97","author":"Menczer J","year":"2005","unstructured":"Menczer J, Levy T, Piura B, et al.. A comparison between different postoperative treatment modalities of uterine carcinosarcoma. Gynecol Oncol. 2005, 97:166-70. 10.1016\/j.ygyno.2004.12.006","journal-title":"Gynecol Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s004040100222","article-title":"Treatment of uterine sarcoma. A survey of 49 patients","volume":"266","author":"Soumarov\u00e1 R","year":"2002","unstructured":"Soumarov\u00e1 R, Horov\u00e1 H, Seneklov\u00e1 Z, et al.. Treatment of uterine sarcoma. A survey of 49 patients. Arch Gynecol Obstet. 2002, 266:92-5. 10.1007\/s004040100222","journal-title":"Arch Gynecol Obstet"},{"key":"ref18","article-title":"Mixed mesodermal tumors of the uterus","volume":"120","author":"Afonso JF","year":"1974","unstructured":"Afonso JF. Mixed mesodermal tumors of the uterus. West J Med. 1974, 120:17-26.","journal-title":"West J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/198380-clinical-profile-and-treatment-outcomes-of-malignant-mixed-mullerian-tumors-of-the-uterus-a-single-center-experience","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:08:59Z","timestamp":1707509339000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/198380-clinical-profile-and-treatment-outcomes-of-malignant-mixed-mullerian-tumors-of-the-uterus-a-single-center-experience"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,31]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.48079","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,31]]}}}